Value Investing News

BioScrip (BIOS) Rises on AmerisourceBergen Deal; Magma Design Automation (LAVA) Picks Up Speed on Product Launch; SciClone (SCLN) Drug Works with Focetria from Novartis.
By Dennis Askew

• http://www.smallcapnetwork.com/Going-it-Alone-Not-in-a-Global-Market-BIOS-LAVA-SCLN/s/article/view/p/mid/1/id/646/ (46)